JB Chemicals & Pharmaceuticals Ltd Stock Price Today (NSE: JBCHEPHARM)
Fundamental Score
JB Chemicals & Pharmaceuticals Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
JB Chemicals & Pharmaceuticals Ltd share price today is ₹2408.90, up +0.00% on NSE/BSE as of 31 July 2026. JB Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) is a Large-cap company in the Pharmaceuticals sector with a market capitalisation of ₹40.25K (Cr). The 52-week high for JBCHEPHARM share price is ₹2525.50 and the 52-week low is ₹1638.50. At a P/E ratio of 56.02x, JBCHEPHARM is currently trading above its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 18.93% and a debt-to-equity ratio of 0.00.
JB Chemicals & Pharmaceuticals Ltd Share Price Chart — NSE/BSE Historical Performance
JB Chemicals & Pharmaceuticals Ltd share price chart: 7.68% return over the past month. 52-week high ₹2525.50, 52-week low ₹1638.50.
JB Chemicals & Pharmaceuticals Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹2408.90 | ₹2408.90 | ₹2408.90 | ₹2408.90 | 0.00 (Cr) | |
| ₹2408.90 | ₹2408.90 | ₹2408.90 | ₹2408.90 | 0.00 (Cr) | |
| ₹2408.90 | ₹2408.90 | ₹2408.90 | ₹2408.90 | 0.00 (Cr) | |
| ₹2408.90 | ₹2408.90 | ₹2408.90 | ₹2408.90 | 0.00 (Cr) | |
| ₹2408.90 | ₹2408.90 | ₹2408.90 | ₹2408.90 | 0.00 (Cr) | |
| ₹2506.00 | ₹2525.50 | ₹2380.00 | ₹2408.90 | 47.79L (Cr) | |
| ₹2491.00 | ₹2510.00 | ₹2441.30 | ₹2506.00 | 7.18L (Cr) | |
| ₹2460.00 | ₹2491.00 | ₹2449.10 | ₹2487.60 | 8.38L (Cr) | |
| ₹2415.20 | ₹2470.00 | ₹2406.60 | ₹2460.00 | 4.55L (Cr) | |
| ₹2440.00 | ₹2444.80 | ₹2386.80 | ₹2435.50 | 4.12L (Cr) |
JB Chemicals & Pharmaceuticals Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹2295.00 | ₹2525.50 | ₹2267.10 | ₹2408.90 | +4.96% | |
| ₹2160.70 | ₹2317.50 | ₹2080.90 | ₹2295.90 | +6.26% | |
| ₹2043.40 | ₹2285.30 | ₹2043.40 | ₹2167.40 | +6.07% | |
| ₹2071.90 | ₹2103.00 | ₹1892.60 | ₹2043.40 | -1.38% | |
| ₹1976.20 | ₹2195.00 | ₹1974.00 | ₹2064.40 | +4.46% | |
| ₹1875.00 | ₹2114.70 | ₹1830.60 | ₹2053.50 | +9.52% | |
| ₹1828.60 | ₹1939.00 | ₹1775.80 | ₹1869.50 | +2.24% | |
| ₹1771.30 | ₹1842.50 | ₹1749.50 | ₹1819.70 | +2.73% | |
| ₹1690.90 | ₹1844.00 | ₹1675.00 | ₹1771.30 | +4.75% | |
| ₹1695.00 | ₹1721.50 | ₹1644.60 | ₹1682.30 | -0.75% | |
| ₹1721.40 | ₹1745.00 | ₹1638.50 | ₹1709.70 | -0.68% | |
| ₹1694.00 | ₹1762.50 | ₹1647.70 | ₹1724.30 | +1.79% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
JB Chemicals & Pharmaceuticals Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
JB Chemicals & Pharmaceuticals Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of JBCHEPHARM across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Return on Equity (18.93%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (25.45%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (24.97%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Consistent Growth Track Record (15.22% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (174.16x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹1278.68 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Strong Institutional Confidence (FII+DII: 37.71%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Premium Valuation Risk (P/E: 56.02x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-16.99%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
JB Chemicals & Pharmaceuticals Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare JB Chemicals & Pharmaceuticals Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
JB Chemicals & Pharmaceuticals LtdJB Chemicals & ...Selected✓ JBCHEPHARM • 506943 | 53.9/100 | ₹2408.90₹2409 | ₹40248.14₹40248.14 | 56.02Average 56.0 Average | 18.93%Good 18.93% Good | 25.45%Excellent 25.45% Excellent | 0.00Excellent 0.0 Excellent | 12.37%Good 12.37% Good | 15.22%Excellent 15.22% Excellent | 0.88% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1990.50₹1991 | ₹468821.49₹468821.49 | 37.73Average 37.7 Average | 15.95%Good 15.95% Good | 20.53%Excellent 20.53% Excellent | 0.06Excellent 0.1 Excellent | 16.75%Excellent 16.75% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 56.3/100 | ₹8056.00₹8056 | ₹193163.97₹193163.97 | 73.64Average 73.6 Average | 16.53%Good 16.53% Good | 21.96%Excellent 21.96% Excellent | 0.00Excellent 0.0 Excellent | 5.71%Good 5.71% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹5122.80₹5123 | ₹169902.02₹169902.02 | 77.52Average 77.5 Average | 27.43%Excellent 27.43% Excellent | 15.19%Good 15.19% Good | 1.79Average 1.8 Average | 12.07%Good 12.07% Good | 11.80%Good 11.80% Good | 0.76% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 40.2/100 | ₹1473.20₹1473 | ₹116131.81₹116131.81 | 30.51Average 30.5 Average | 11.60%Average 11.60% Average | 15.49%Good 15.49% Good | 0.02Excellent 0.0 Excellent | 9.94%Good 9.94% Good | 8.01%Good 8.01% Good | 0.90% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1078.30₹1078 | ₹115375.77₹115375.77 | 21.26Average 21.3 Average | 21.25%Excellent 21.25% Excellent | 21.14%Excellent 21.14% Excellent | 0.46Excellent 0.5 Excellent | 18.77%Excellent 18.77% Excellent | 12.45%Good 12.45% Good | 0.09% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 83.4/100 | ₹2415.00₹2415 | ₹113976.53₹113976.53 | 20.04Average 20.0 Average | 28.68%Excellent 28.68% Excellent | 29.93%Excellent 29.93% Excellent | 0.29Excellent 0.3 Excellent | 37.02%Excellent 37.02% Excellent | 13.02%Good 13.02% Good | 0.72% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2469.60₹2470 | ₹105053.91₹105053.91 | 52.29Average 52.3 Average | 13.12%Average 13.12% Average | 13.50%Average 13.50% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 41/100 | ₹1148.10₹1148 | ₹102660.46₹102660.46 | 25.62Average 25.6 Average | 11.22%Average 11.22% Average | 13.04%Average 13.04% Average | 0.20Excellent 0.2 Excellent | 15.44%Excellent 15.44% Excellent | 12.09%Good 12.09% Good | 0.65% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1580.20₹1580 | ₹90035.87₹90035.87 | 25.38Average 25.4 Average | 10.06%Average 10.06% Average | 12.80%Average 12.80% Average | 0.21Excellent 0.2 Excellent | 0.80%Average 0.80% Average | 6.32%Good 6.32% Good | 0.26% |
Laurus Labs LtdLaurus Labs Ltd... LAURUSLABS • 540222 | 34.1/100 | ₹1816.20₹1816 | ₹84016.75₹84016.75 | 93.94Average 93.9 Average | 18.30%Good 18.30% Good | 17.76%Good 17.76% Good | 0.48Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price468821.49 Cr
- Divis Laboratories Ltd share price193163.97 Cr
- Torrent Pharmaceuticals Ltd share price169902.02 Cr
- Cipla Ltd share price116131.81 Cr
- Zydus Lifesciences Ltd share price115375.77 Cr
JB Chemicals & Pharmaceuticals Ltd PE Ratio History
Historical price-to-earnings ratio for JBCHEPHARM — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹41.56 | ₹1819.70 | 43.8x |
| FY 2024 | ₹34.85 | ₹1844.15 | 52.9x |
| FY 2023 | ₹26.17 | ₹1624.65 | 62.1x |
| FY 2022 | ₹24.91 | ₹972.25 | 39x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
JB Chemicals & Pharmaceuticals Ltd Dividend History
Annual cash dividends paid by JBCHEPHARM — dividend yield 0.88%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹237.04 Cr |
| FY 2024 | ₹156.99 Cr |
| FY 2023 | ₹127.59 Cr |
| FY 2022 | ₹127.56 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
JB Chemicals & Pharmaceuticals Ltd Quarterly Performance
Latest quarterly metrics for JBCHEPHARM — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-4.77%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-16.99%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
15.22%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
12.37%
Compounded annual net profit growth over 5 years
JB Chemicals & Pharmaceuticals Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for JBCHEPHARM — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
JB Chemicals & Pharmaceuticals Ltd Financial Statements
Annual income statement, balance sheet and cash flow for JB Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for JB Chemicals & Pharmaceuticals Ltd
About JBCHEPHARM (JB Chemicals & Pharmaceuticals Ltd)
JB Chemicals & Pharmaceuticals Ltd is a prominent player in the global pharmaceutical landscape, distinguished by its commitment to developing and delivering a diverse range of hea...lthcare solutions. From its robust research and development initiatives to its state-of-the-art manufacturing facilities, the company prioritizes innovation and quality across its operations. With a portfolio encompassing both branded formulations and generic medications, JBCHEPHARM addresses a wide spectrum of medical needs, serving patients and healthcare providers in numerous therapeutic areas. The company's dedication to ethical business practices and patient safety underscores its reputation as a trusted partner in the healthcare industry. JBCHEPHARM’s strength lies in its comprehensive product offerings, which span various therapeutic categories. The company develops and manufactures a wide array of pharmaceutical products. This includes tablets, capsules, creams, and injectables. These products serve the needs of patients across the globe. With a strong emphasis on research and development, JBCHEPHARM continuously strives to innovate and introduce novel therapies to address unmet medical needs. Moreover, the company's commitment to quality and regulatory compliance ensures that its products meet the highest standards of safety and efficacy. Beyond its product portfolio, JBCHEPHARM distinguishes itself through its expansive global presence and strategic partnerships. The company's products are marketed and distributed in numerous countries, reaching patients and healthcare providers in diverse regions. Through collaborations with leading pharmaceutical companies and research institutions, JBCHEPHARM leverages its expertise and resources to expand its reach and impact. With a strong focus on customer satisfaction and long-term sustainability, JBCHEPHARM is committed to making a meaningful contribution to the healthcare industry and improving the lives of patients worldwide.
Company Details
Key Leadership
Corporate Events
JBCHEPHARM Share Price: Frequently Asked Questions
What is the current share price of JB Chemicals & Pharmaceuticals Ltd?
JB Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) trades at ₹2408.90 on NSE and BSE. Market cap ₹40.25K (Cr). Educational data only.
What is the P/E ratio of JB Chemicals & Pharmaceuticals Ltd?
JB Chemicals & Pharmaceuticals Ltd has a P/E of 56.02x vs industry average 34.89x.
What is the Bull Run score for JB Chemicals & Pharmaceuticals Ltd?
JB Chemicals & Pharmaceuticals Ltd has a Bull Run score of 53.9/100 based on 25+ financial parameters.
Does JB Chemicals & Pharmaceuticals Ltd pay dividends?
JB Chemicals & Pharmaceuticals Ltd has a dividend yield of 0.88%. Past dividends don't guarantee future payments.
What is the ROE of JB Chemicals & Pharmaceuticals Ltd?
JB Chemicals & Pharmaceuticals Ltd has ROE of 18.93%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of JB Chemicals & Pharmaceuticals Ltd?
JB Chemicals & Pharmaceuticals Ltd has debt-to-equity of 0.00.
Is JB Chemicals & Pharmaceuticals Ltd a good investment?
Bull Run gives JB Chemicals & Pharmaceuticals Ltd a score of 53.9/100. This is not investment advice — consult a SEBI-registered advisor.